SCHEMBL23764023

SCHEMBL23764023

CCCCc1nc(N)c2ncn(Cc3ccc(CN(C)C)cc3)c2n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 3/20 0.46
▸ TLR8 Q9NR97 1/20 0.46
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ ADORA2A P29274 4/20 0.41
▸ ADORA1 P30542 2/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CCNE1 P24864 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ PDE8A O60658 1/20 0.40
▸ TMIGD3 P0DMS9 1/20 0.40
▸ PI4KA P42356 1/20 0.40
▸ PI4K2B Q8TCG2 1/20 0.40
▸ PI4K2A Q9BTU6 1/20 0.40
▸ PI4KB Q9UBF8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23420269 0.86 PDE4A (0.42) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL7491638 0.86 PDE4A (0.58) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL6153383 0.83 PDE4A (0.57) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL6153440 0.82 PDE4A (0.56) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL27804178 0.82 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL23764385 0.81 PDE8A (0.59) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL23764021 0.81 ADORA2A (0.43) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL1146640 0.80 PNP (0.40) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL21076558 0.80 TLR7 (0.57) TLR7PDE4APDE4BPDE4CPDE4D
SCHEMBL23422306 0.80 ADORA2A (0.43) TLR7PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3450433-B1 PURINE DERIVATIVES AS TLR7 INHIBITORS FOR TREATING E.G. SYSTEMIC LUPUS ERYTHEMATOSUS SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2021-08-18 — — EP disclosed
Send feedback